Lv1
70 积分 2025-05-25 加入
Lineage plasticity: a new dilemma in lung cancer treatment
4天前
已完结
Small cell lung cancer transdifferentiation: not a negligible phenomenon
4天前
已完结
Antibody-drug conjugates: new drugs – new toxicities
9天前
已完结
The Story of EGFR: From Signaling Pathways to a Potent Anticancer Target
12天前
已完结
Incidence of antibody–drug conjugate-related fatigue in patients with breast cancer: A systematic review and meta-analysis
14天前
已完结
Epidermal growth factor receptor inhibitor-related skin toxicities: a review of management and possible preventive and therapeutic approaches for Asian patients by the Japanese Pharmacist-led Oncodermatology Study Team
16天前
已关闭
Adverse Event Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-small Cell Lung Cancer: An Updated Meta-analysis
17天前
已完结
Molecular Landscape and Therapeutic Strategies of Lung Cancer Lineage Plasticity
1个月前
已完结
Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC — mechanisms and evolving treatment approaches
1个月前
已完结
Rationale and Design of a Phase II Trial of Combined Serplulimab and Chemotherapy in Patients with Histologically Transformed Small Cell Lung Cancer: a Prospective, Single-arm and Multicentre Study
1个月前
已完结
皖公网安备34019202002308
